Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    21459215 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
Condition: Macular Edema, Diabetic
Intervention: Drug: aflibercept
2 Completed
Has Results
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Procedure: Laser;   Procedure: Sham laser;   Drug: Sham to ranibizumab
3 Recruiting Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Ozurdex;   Drug: Lucentis

Study has passed its completion date and status has not been verified in more than two years.